Literature DB >> 28876403

Antimicrobial drug-related problems in a neonatal intensive care unit.

Bruna Meirelly Nunes1, Tatiana Costa Xavier1, Rand Randall Martins2.   

Abstract

OBJECTIVE: The goal was to determine the main drug-related problems in neonates who were using antimicrobials.
METHOD: This was an observational, prospective and longitudinal study. Drug-related problems were classified according to version 6.2 of the Pharmaceutical Care Network Europe Foundation classification. A descriptive analysis was performed, in which the clinical and therapeutic variables were presented as absolute and relative frequencies or as the mean and standard deviation, as appropriate.
RESULTS: In total, 152 neonates with a predominance of males (58.5%), gestational age of 32.7 ± 4.2 weeks and weight of 1,903.1 ± 846.9g were included. The main diagnostic hypothesis of infection was early sepsis (66.5%), and 71.7% of the neonates had some risk factor for infection. Among the neonates, 33.6% had at least one drug-related problem. Of these, 84.8% were related to treatment effectiveness and 15.2% to adverse reactions. The main cause of drug-related problems was the selected dose, particularly for aminoglycosides and cephalosporins.
CONCLUSION: The use of antimicrobials in the neonatal intensive care is mainly associated with problems related to medication effectiveness, predominantly the prescription of subdoses of antimicrobials, especially aminoglycosides.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28876403      PMCID: PMC5632976          DOI: 10.5935/0103-507X.20170040

Source DB:  PubMed          Journal:  Rev Bras Ter Intensiva        ISSN: 0103-507X


  23 in total

1.  Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues.

Authors:  Barbara J Stoll; Nellie I Hansen; Pablo J Sánchez; Roger G Faix; Brenda B Poindexter; Krisa P Van Meurs; Matthew J Bizzarro; Ronald N Goldberg; Ivan D Frantz; Ellen C Hale; Seetha Shankaran; Kathleen Kennedy; Waldemar A Carlo; Kristi L Watterberg; Edward F Bell; Michele C Walsh; Kurt Schibler; Abbot R Laptook; Andi L Shane; Stephanie J Schrag; Abhik Das; Rosemary D Higgins
Journal:  Pediatrics       Date:  2011-04-25       Impact factor: 7.124

2.  Prescribing errors in a Brazilian neonatal intensive care unit.

Authors:  Ana Paula Cezar Machado; Catharina Somerlate Franco Tomich; Simone Franco Osme; Daniela Marques de Lima Mota Ferreira; Maria Angélica Oliveira Mendonça; Rogério Melo Costa Pinto; Nilson Penha-Silva; Vânia Olivetti Steffen Abdallah
Journal:  Cad Saude Publica       Date:  2015-12       Impact factor: 1.632

3.  Prospective, controlled study of an intervention to reduce errors in neonatal antibiotic orders.

Authors:  S S Garner; T H Cox; E G Hill; M G Irving; R L Bissinger; D J Annibale
Journal:  J Perinatol       Date:  2015-04-02       Impact factor: 2.521

4.  The antibiotic resistance crisis: part 1: causes and threats.

Authors:  C Lee Ventola
Journal:  P T       Date:  2015-04

5.  Compliance with dosing recommendations from common references in prescribing antibiotics for preterm neonates.

Authors:  Ching-Lan Cheng; Yea-Huei Kao Yang; Swu-Jane Lin; Chyi-Her Lin; Yuh-Jyh Lin
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-01       Impact factor: 2.890

6.  High-dose gentamicin in newborn infants: is it safe?

Authors:  Jon Widding Fjalstad; Einar Laukli; John N van den Anker; Claus Klingenberg
Journal:  Eur J Pediatr       Date:  2013-11-14       Impact factor: 3.183

7.  Neonatal sepsis: a 6-year analysis in a neonatal care unit in Taiwan.

Authors:  Jun-Ho Wu; Chien-Yi Chen; Po-Nien Tsao; Wu-Shiun Hsieh; Hung-Chieh Chou
Journal:  Pediatr Neonatol       Date:  2009-06       Impact factor: 2.083

8.  [Medication errors in a neonatal unit: One of the main adverse events].

Authors:  M T Esqué Ruiz; M G Moretones Suñol; J M Rodríguez Miguélez; E Sánchez Ortiz; M Izco Urroz; M de Lamo Camino; J Figueras Aloy
Journal:  An Pediatr (Barc)       Date:  2015-10-28       Impact factor: 1.500

Review 9.  Burden of bacterial resistance among neonatal infections in low income countries: how convincing is the epidemiological evidence?

Authors:  Bich-Tram Huynh; Michael Padget; Benoit Garin; Perlinot Herindrainy; Elsa Kermorvant-Duchemin; Laurence Watier; Didier Guillemot; Elisabeth Delarocque-Astagneau
Journal:  BMC Infect Dis       Date:  2015-03-15       Impact factor: 3.090

Review 10.  Medication errors in the Middle East countries: a systematic review of the literature.

Authors:  Zayed Alsulami; Sharon Conroy; Imti Choonara
Journal:  Eur J Clin Pharmacol       Date:  2012-10-23       Impact factor: 2.953

View more
  4 in total

1.  Determinants of late neonatal nosocomial infection: a case-control study in Ceará.

Authors:  Carmen Sulinete Suliano da Costa Lima; Hermano Alexandre Lima Rocha; David Augusto Batista Sá Araújo; Cláudia Silva
Journal:  Rev Saude Publica       Date:  2022-05-27       Impact factor: 2.772

2.  Drug-related problems and its determinant among hospitalized neonates with sepsis at Jimma University Medical Center, Ethiopia: a prospective observational study.

Authors:  Mengist Awoke; Tsegaye Melaku; Mohammed Beshir
Journal:  J Pharm Health Care Sci       Date:  2021-06-01

3.  Efficacy of pentoxifylline treatment for neonatal sepsis: a meta-analysis of randomized controlled studies.

Authors:  Jun Tian; Peifang Shen; Kaiyu Pan; Qiong Zhou
Journal:  Ital J Pediatr       Date:  2019-08-22       Impact factor: 2.638

4.  Systematic review of the prevalence and nature of drug-related problems in paediatric patients.

Authors:  Xue Mi; Linan Zeng; Lingli Zhang
Journal:  J Clin Pharm Ther       Date:  2022-01-30       Impact factor: 2.145

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.